{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:10:30Z","timestamp":1794449430726,"version":"4.9.1"},"reference-count":118,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NJCCR-COCR23PDFOOS"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intra-tumor heterogeneity contributes to treatment failure and poor survival in urothelial bladder carcinoma (UBC). Analyzing transcriptome from a UBC cohort, we report that intra-tumor transcriptomic heterogeneity indicates co-existence of tumor cells in epithelial and mesenchymal-like transcriptional states and bi-directional transition between them occurs within and between tumor subclones. We model spontaneous and reversible transition between these partially heritable states in cell lines and characterize their population dynamics. SMAD3, KLF4 and PPARG emerge as key regulatory markers of the transcriptional dynamics. Nutrient limitation, as in the core of large tumors, and radiation treatment perturb the dynamics, initially selecting for a transiently resistant phenotype and then reconstituting heterogeneity and growth potential, driving adaptive evolution. Dominance of transcriptional states with low <jats:italic>PPARG<\/jats:italic> expression indicates an aggressive phenotype in UBC patients. We propose that phenotypic plasticity and dynamic, non-genetic intra-tumor heterogeneity modulate both the trajectory of disease progression and adaptive treatment response in UBC.<\/jats:p>","DOI":"10.1038\/s42003-023-05668-3","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T10:02:37Z","timestamp":1703152957000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Transcriptional state dynamics lead to heterogeneity and adaptive tumor evolution in urothelial bladder carcinoma"],"prefix":"10.1038","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3288-4528","authenticated-orcid":false,"given":"Antara","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarthak","family":"Sahoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Riedlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saum","family":"Ghodoussipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6631-2109","authenticated-orcid":false,"given":"Mohit K.","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2313-8593","authenticated-orcid":false,"given":"Subhajyoti","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,21]]},"reference":[{"key":"5668_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA: a cancer J. Clin."},{"key":"5668_CR2","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis, A. T., Lec, P. M. & Chamie, K. Bladder cancer: a review. Jama 324, 1980\u20131991 (2020).","journal-title":"Jama"},{"key":"5668_CR3","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s40273-014-0194-2","volume":"32","author":"C Yeung","year":"2014","unstructured":"Yeung, C., Dinh, T. & Lee, J. The health economics of bladder cancer: an updated review of the published literature. Pharmacoeconomics 32, 1093\u20131104 (2014).","journal-title":"Pharmacoeconomics"},{"key":"5668_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41585-020-0304-1","volume":"17","author":"JJ Meeks","year":"2020","unstructured":"Meeks, J. J. et al. Genomic heterogeneity in bladder cancer: challenges and possible solutions to improve outcomes. Nat. Rev. Urol. 17, 259\u2013270 (2020).","journal-title":"Nat. Rev. Urol."},{"key":"5668_CR5","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran, L., Xiao, J.-F., Agarwal, N., Duex, J. E. & Theodorescu, D. Advances in bladder cancer biology and therapy. Nat. Rev. Cancer 21, 104\u2013121 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"5668_CR6","first-page":"1","volume":"3","author":"O Sanli","year":"2017","unstructured":"Sanli, O. et al. Bladder cancer. Nat. Rev. Dis. Prim. 3, 1\u201319 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"5668_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","volume":"15","author":"MA Knowles","year":"2015","unstructured":"Knowles, M. A. & Hurst, C. D. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat. Rev. cancer 15, 25\u201341 (2015).","journal-title":"Nat. Rev. cancer"},{"key":"5668_CR8","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/ijc.33794","volume":"149","author":"H Lai","year":"2021","unstructured":"Lai, H. et al. Single\u2010cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer. Int. J. cancer 149, 2099\u20132115 (2021).","journal-title":"Int. J. cancer"},{"key":"5668_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-020-00741-6","volume":"12","author":"HW Lee","year":"2020","unstructured":"Lee, H. W. et al. Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient. Genome Med. 12, 1\u201321 (2020).","journal-title":"Genome Med."},{"key":"5668_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18916-5","volume":"11","author":"Z Chen","year":"2020","unstructured":"Chen, Z. et al. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat. Commun. 11, 5077 (2020).","journal-title":"Nat. Commun."},{"key":"5668_CR11","doi-asserted-by":"crossref","unstructured":"Househam, J. et al. Phenotypic plasticity and genetic control in colorectal cancer evolution. Nature 611, 1\u201310 (2022).","DOI":"10.1038\/s41586-022-05311-x"},{"key":"5668_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.trecan.2019.09.002","volume":"5","author":"D Barkley","year":"2019","unstructured":"Barkley, D. & Yanai, I. Plasticity and clonality of cancer cell states. Trends cancer 5, 655\u2013656 (2019).","journal-title":"Trends cancer"},{"key":"5668_CR13","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41568-021-00336-2","volume":"21","author":"JR Black","year":"2021","unstructured":"Black, J. R. & McGranahan, N. Genetic and non-genetic clonal diversity in cancer evolution. Nat. Rev. Cancer 21, 379\u2013392 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"5668_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41573-019-0044-1","volume":"19","author":"S Boumahdi","year":"2020","unstructured":"Boumahdi, S. & de Sauvage, F. J. The great escape: tumour cell plasticity in resistance to targeted therapy. Nat. Rev. Drug Discov. 19, 39\u201356 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"5668_CR15","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1038\/s41571-020-0340-z","volume":"17","author":"\u00c1 Quintanal-Villalonga","year":"2020","unstructured":"Quintanal-Villalonga, \u00c1. et al. Lineage plasticity in cancer: a shared pathway of therapeutic resistance. Nat. Rev. Clin. Oncol. 17, 360\u2013371 (2020).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"5668_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41523-017-0012-z","volume":"3","author":"GM Wahl","year":"2017","unstructured":"Wahl, G. M. & Spike, B. T. Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity. NPJ breast cancer 3, 1\u201313 (2017).","journal-title":"NPJ breast cancer"},{"key":"5668_CR17","doi-asserted-by":"publisher","first-page":"eabj8002","DOI":"10.1126\/sciadv.abj8002","volume":"8","author":"MS Brown","year":"2022","unstructured":"Brown, M. S. et al. Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer. Sci. Adv. 8, eabj8002 (2022).","journal-title":"Sci. Adv."},{"key":"5668_CR18","doi-asserted-by":"publisher","first-page":"e10105","DOI":"10.15252\/msb.202010105","volume":"17","author":"I Larsson","year":"2021","unstructured":"Larsson, I. et al. Modeling glioblastoma heterogeneity as a dynamic network of cell states. Mol. Syst. Biol. 17, e10105 (2021).","journal-title":"Mol. Syst. Biol."},{"key":"5668_CR19","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1038\/s41588-021-00927-7","volume":"53","author":"R Chaligne","year":"2021","unstructured":"Chaligne, R. et al. Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states. Nat. Genet. 53, 1469\u20131479 (2021).","journal-title":"Nat. Genet."},{"key":"5668_CR20","doi-asserted-by":"publisher","first-page":"e12670","DOI":"10.15252\/emmm.202012670","volume":"13","author":"AC Lewis","year":"2021","unstructured":"Lewis, A. C. & Kats, L. M. Non\u2010genetic heterogeneity, altered cell fate and differentiation therapy. EMBO Mol. Med. 13, e12670 (2021).","journal-title":"EMBO Mol. Med."},{"key":"5668_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/nrg2556","volume":"10","author":"A Brock","year":"2009","unstructured":"Brock, A., Chang, H. & Huang, S. Non-genetic heterogeneity\u2014a mutation-independent driving force for the somatic evolution of tumours. Nat. Rev. Genet. 10, 336\u2013342 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"5668_CR22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.ccell.2020.03.007","volume":"37","author":"A Marusyk","year":"2020","unstructured":"Marusyk, A., Janiszewska, M. & Polyak, K. Intratumor heterogeneity: the rosetta stone of therapy resistance. Cancer cell 37, 471\u2013484 (2020).","journal-title":"Cancer cell"},{"key":"5668_CR23","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1101\/gr.275308.121","volume":"31","author":"D Barkley","year":"2021","unstructured":"Barkley, D., Rao, A., Pour, M., Fran\u00e7a, G. S. & Yanai, I. Cancer cell states and emergent properties of the dynamic tumor system. Genome Res. 31, 1719\u20131727 (2021).","journal-title":"Genome Res."},{"key":"5668_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature12624","volume":"501","author":"CE Meacham","year":"2013","unstructured":"Meacham, C. E. & Morrison, S. J. Tumour heterogeneity and cancer cell plasticity. Nature 501, 328\u2013337 (2013).","journal-title":"Nature"},{"key":"5668_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","volume":"27","author":"I Vitale","year":"2021","unstructured":"Vitale, I., Shema, E., Loi, S. & Galluzzi, L. Intratumoral heterogeneity in cancer progression and response to immunotherapy. Nat. Med. 27, 212\u2013224 (2021).","journal-title":"Nat. Med."},{"key":"5668_CR26","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson, A. G. et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 171, 540\u2013556.e525 (2017).","journal-title":"Cell"},{"key":"5668_CR27","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1056\/NEJMp1607591","volume":"375","author":"RL Grossman","year":"2016","unstructured":"Grossman, R. L. et al. Toward a shared vision for cancer genomic data. N. Engl. J. Med. 375, 1109\u20131112 (2016).","journal-title":"N. Engl. J. Med."},{"key":"5668_CR28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","author":"CGAR Network","year":"2014","unstructured":"Network, C. G. A. R. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315 (2014).","journal-title":"Nature"},{"key":"5668_CR29","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1073\/pnas.1318376111","volume":"111","author":"JS Damrauer","year":"2014","unstructured":"Damrauer, J. S. et al. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc. Natl Acad. Sci. 111, 3110\u20133115 (2014).","journal-title":"Proc. Natl Acad. Sci."},{"key":"5668_CR30","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1016\/j.celrep.2019.10.045","volume":"29","author":"A Sharma","year":"2019","unstructured":"Sharma, A. et al. Non-genetic intra-tumor heterogeneity is a major predictor of phenotypic heterogeneity and ongoing evolutionary dynamics in lung tumors. Cell Rep. 29, 2164\u20132174.e2165 (2019).","journal-title":"Cell Rep."},{"key":"5668_CR31","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci."},{"key":"5668_CR32","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1073\/pnas.84.8.2302","volume":"84","author":"Y Barrandon","year":"1987","unstructured":"Barrandon, Y. & Green, H. Three clonal types of keratinocyte with different capacities for multiplication. Proc. Natl Acad. Sci. 84, 2302\u20132306 (1987).","journal-title":"Proc. Natl Acad. Sci."},{"key":"5668_CR33","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/cbin.11109","volume":"43","author":"M Buhl","year":"2019","unstructured":"Buhl, M. et al. The different expression of key markers on urothelial holoclonal, meroclonal, and paraclonal cells in in vitro culture. Cell Biol. Int. 43, 456\u2013465 (2019).","journal-title":"Cell Biol. Int."},{"key":"5668_CR34","doi-asserted-by":"publisher","first-page":"e89834","DOI":"10.1371\/journal.pone.0089834","volume":"9","author":"CM Beaver","year":"2014","unstructured":"Beaver, C. M., Ahmed, A. & Masters, J. R. Clonogenicity: holoclones and meroclones contain stem cells. PLoS One 9, e89834 (2014).","journal-title":"PLoS One"},{"key":"5668_CR35","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ncb2764","volume":"15","author":"Z Yin","year":"2013","unstructured":"Yin, Z. et al. A screen for morphological complexity identifies regulators of switch-like transitions between discrete cell shapes. Nat. cell Biol. 15, 860\u2013871 (2013).","journal-title":"Nat. cell Biol."},{"key":"5668_CR36","doi-asserted-by":"publisher","first-page":"eaaw6938","DOI":"10.1126\/sciadv.aaw6938","volume":"6","author":"P-H Wu","year":"2020","unstructured":"Wu, P.-H. et al. Single-cell morphology encodes metastatic potential. Sci. Adv. 6, eaaw6938 (2020).","journal-title":"Sci. Adv."},{"key":"5668_CR37","doi-asserted-by":"publisher","first-page":"810286","DOI":"10.3389\/fimmu.2021.810286","volume":"12","author":"Z-w Liu","year":"2022","unstructured":"Liu, Z.-w et al. Duality of interactions between TGF-\u03b2 and TNF-\u03b1 during tumor formation. Front. Immunol. 12, 810286 (2022).","journal-title":"Front. Immunol."},{"key":"5668_CR38","doi-asserted-by":"crossref","unstructured":"Zou, J. et al. Secreted TGF-beta-induced protein promotes aggressive progression in bladder cancer cells. Cancer Manage. Res. 11, 6995\u20137006 (2019).","DOI":"10.2147\/CMAR.S208984"},{"key":"5668_CR39","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41419-021-03920-4","volume":"12","author":"M Adjuto-Saccone","year":"2021","unstructured":"Adjuto-Saccone, M. et al. TNF-\u03b1 induces endothelial\u2013mesenchymal transition promoting stromal development of pancreatic adenocarcinoma. Cell death Dis. 12, 649 (2021).","journal-title":"Cell death Dis."},{"key":"5668_CR40","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. cell 126, 663\u2013676 (2006).","journal-title":"cell"},{"key":"5668_CR41","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1165\/rcmb.2006-0043OC","volume":"36","author":"B Hu","year":"2007","unstructured":"Hu, B. et al. Gut-enriched Kruppel-like factor interaction with Smad3 inhibits myofibroblast differentiation. Am. J. Respirat. cell Mol. Biol. 36, 78\u201384 (2007).","journal-title":"Am. J. Respirat. cell Mol. Biol."},{"key":"5668_CR42","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.1074\/jbc.M111.317487","volume":"288","author":"S Li","year":"2013","unstructured":"Li, S., Zhou, Q., He, H., Zhao, Y. & Liu, Z. Peroxisome proliferator-activated receptor \u03b3 agonists induce cell cycle arrest through transcriptional regulation of Kr\u00fcppel-like factor 4 (KLF4). J. Biol. Chem. 288, 4076\u20134084 (2013).","journal-title":"J. Biol. Chem."},{"key":"5668_CR43","doi-asserted-by":"crossref","unstructured":"Lakshmi, S. P., Reddy, A. T., Banno, A. & Reddy, R. C. PPAR agonists for the prevention and treatment of lung cancer. PPAR Res. 2017, 8252796 (2017).","DOI":"10.1155\/2017\/8252796"},{"key":"5668_CR44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.bbrc.2006.09.069","volume":"350","author":"C Zhao","year":"2006","unstructured":"Zhao, C. et al. PPAR\u03b3 agonists prevent TGF\u03b21\/Smad3-signaling in human hepatic stellate cells. Biochem. Biophys. Res. Commun. 350, 385\u2013391 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"5668_CR45","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1111\/jcmm.14882","volume":"24","author":"Z Leng","year":"2020","unstructured":"Leng, Z. et al. Kr\u00fcppel\u2010like factor 4 regulates stemness and mesenchymal properties of colorectal cancer stem cells through the TGF\u2010\u03b21\/Smad\/snail pathway. J. Cell. Mol. Med. 24, 1866\u20131877 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"5668_CR46","doi-asserted-by":"publisher","first-page":"F898","DOI":"10.1152\/ajprenal.00335.2010","volume":"300","author":"RK Basu","year":"2011","unstructured":"Basu, R. K. et al. Interdependence of HIF-1\u03b1 and TGF-\u03b2\/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression. Am. J. Physiol.-Ren. Physiol. 300, F898\u2013F905 (2011).","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"5668_CR47","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/jcp.28953","volume":"235","author":"F Shan","year":"2020","unstructured":"Shan, F., Huang, Z., Xiong, R., Huang, Q. Y. & Li, J. HIF1\u03b1\u2010induced upregulation of KLF4 promotes migration of human vascular smooth muscle cells under hypoxia. J. Cell. Physiol. 235, 141\u2013150 (2020).","journal-title":"J. Cell. Physiol."},{"key":"5668_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-27499-8","volume":"12","author":"RR Chandran","year":"2021","unstructured":"Chandran, R. R. et al. Distinct roles of KLF4 in mesenchymal cell subtypes during lung fibrogenesis. Nat. Commun. 12, 1\u201317 (2021).","journal-title":"Nat. Commun."},{"key":"5668_CR49","doi-asserted-by":"publisher","first-page":"e3010","DOI":"10.1038\/cddis.2017.331","volume":"8","author":"J Li","year":"2017","unstructured":"Li, J. et al. MET\/SMAD3\/SNAIL circuit mediated by miR-323a-3p is involved in regulating epithelial\u2013mesenchymal transition progression in bladder cancer. Cell death Dis. 8, e3010\u2013e3010 (2017).","journal-title":"Cell death Dis."},{"key":"5668_CR50","doi-asserted-by":"crossref","unstructured":"Estrada, C. C. et al. Kr\u00fcppel-like factor 4 is a negative regulator of STAT3-induced glomerular epithelial cell proliferation. JCI insight 3, e98214 (2018).","DOI":"10.1172\/jci.insight.98214"},{"key":"5668_CR51","doi-asserted-by":"publisher","first-page":"1098999","DOI":"10.3389\/fped.2023.1098999","volume":"11","author":"SP Bhavsar","year":"2023","unstructured":"Bhavsar, S. P. et al. Hsa-miR-323a-3p functions as a tumor suppressor and targets STAT3 in neuroblastoma cells. Front. Pediatr 11, 1098999 (2023).","journal-title":"Front. Pediatr"},{"key":"5668_CR52","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1093\/abbs\/gmx118","volume":"50","author":"Y Itoh","year":"2018","unstructured":"Itoh, Y., Saitoh, M. & Miyazawa, K. Smad3\u2013STAT3 crosstalk in pathophysiological contexts. Acta biochim. et. biophys. Sin. 50, 82\u201390 (2018).","journal-title":"Acta biochim. et. biophys. Sin."},{"key":"5668_CR53","doi-asserted-by":"publisher","first-page":"e1005456","DOI":"10.1371\/journal.pcbi.1005456","volume":"13","author":"B Huang","year":"2017","unstructured":"Huang, B. et al. Interrogating the topological robustness of gene regulatory circuits by randomization. PLoS Comput. Biol. 13, e1005456 (2017).","journal-title":"PLoS Comput. Biol."},{"key":"5668_CR54","doi-asserted-by":"publisher","first-page":"63138","DOI":"10.18632\/oncotarget.11257","volume":"7","author":"A Peixoto","year":"2016","unstructured":"Peixoto, A. et al. Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension. Oncotarget 7, 63138 (2016).","journal-title":"Oncotarget"},{"key":"5668_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12943-019-1089-9","volume":"18","author":"X Jing","year":"2019","unstructured":"Jing, X. et al. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol. cancer 18, 1\u201315 (2019).","journal-title":"Mol. cancer"},{"key":"5668_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-019-5353-6","volume":"19","author":"CR Goulet","year":"2019","unstructured":"Goulet, C. R. et al. Cancer-associated fibroblasts induce epithelial\u2013mesenchymal transition of bladder cancer cells through paracrine IL-6 signalling. BMC cancer 19, 1\u201313 (2019).","journal-title":"BMC cancer"},{"key":"5668_CR57","doi-asserted-by":"publisher","first-page":"e21043","DOI":"10.1002\/cso2.1043","volume":"2","author":"A Biswas","year":"2022","unstructured":"Biswas, A., Ghaddar, B., Riedlinger, G. & De, S. Inference on spatial heterogeneity in tumor microenvironment using spatial transcriptomics data. Comput. Syst. Oncol. 2, e21043 (2022).","journal-title":"Comput. Syst. Oncol."},{"key":"5668_CR58","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/ncb3013","volume":"16","author":"P Zhang","year":"2014","unstructured":"Zhang, P. et al. ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1. Nat. cell Biol. 16, 864\u2013875 (2014).","journal-title":"Nat. cell Biol."},{"key":"5668_CR59","doi-asserted-by":"publisher","first-page":"595182","DOI":"10.3389\/fonc.2020.595182","volume":"10","author":"X Huang","year":"2021","unstructured":"Huang, X. et al. A combined epithelial mesenchymal transformation and DNA repair gene panel in colorectal cancer with prognostic and therapeutic implication. Front. Oncol. 10, 595182 (2021).","journal-title":"Front. Oncol."},{"key":"5668_CR60","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.7150\/ijbs.40173","volume":"16","author":"H Niu","year":"2020","unstructured":"Niu, H. et al. Knockdown of SMAD3 inhibits the growth and enhances the radiosensitivity of lung adenocarcinoma via p21 in vitro and in vivo. Int. J. Biol. Sci. 16, 1010 (2020).","journal-title":"Int. J. Biol. Sci."},{"key":"5668_CR61","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/jb\/mvy110","volume":"165","author":"Z Jiang","year":"2019","unstructured":"Jiang, Z. et al. SMAD3 silencing enhances DNA damage in radiation therapy by interacting with MRE11-RAD50-NBS1 complex in glioma. J. Biochem. 165, 317\u2013322 (2019).","journal-title":"J. Biochem."},{"key":"5668_CR62","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.stemcr.2017.04.025","volume":"8","author":"Y Li","year":"2017","unstructured":"Li, Y., Xian, M., Yang, B., Ying, M. & He, Q. Inhibition of KLF4 by statins reverses adriamycin-induced metastasis and cancer stemness in osteosarcoma cells. Stem Cell Rep. 8, 1617\u20131629 (2017).","journal-title":"Stem Cell Rep."},{"key":"5668_CR63","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.7150\/jca.42663","volume":"11","author":"T Peng","year":"2020","unstructured":"Peng, T. et al. The role and function of PPAR\u03b3 in bladder cancer. J. Cancer 11, 3965 (2020).","journal-title":"J. Cancer"},{"key":"5668_CR64","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-11-2271","volume":"18","author":"M Riester","year":"2012","unstructured":"Riester, M. et al. Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer. Clin. cancer Res. 18, 1323\u20131333 (2012).","journal-title":"Clin. cancer Res."},{"key":"5668_CR65","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1158\/2326-6066.CIR-15-0274","volume":"4","author":"RF Sweis","year":"2016","unstructured":"Sweis, R. F. et al. Molecular drivers of the non\u2013T-cell-inflamed tumor microenvironment in urothelial bladder cancer. Cancer Immunol. Res. 4, 563\u2013568 (2016).","journal-title":"Cancer Immunol. Res."},{"key":"5668_CR66","doi-asserted-by":"publisher","first-page":"C750","DOI":"10.1152\/ajpcell.00575.2020","volume":"320","author":"A Biswas","year":"2021","unstructured":"Biswas, A. & De, S. Drivers of dynamic intratumor heterogeneity and phenotypic plasticity. Am. J. Physiol.-Cell Physiol. 320, C750\u2013C760 (2021).","journal-title":"Am. J. Physiol.-Cell Physiol."},{"key":"5668_CR67","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.3390\/cancers13061380","volume":"13","author":"Y Shlyakhtina","year":"2021","unstructured":"Shlyakhtina, Y., Moran, K. L. & Portal, M. M. Genetic and non-genetic mechanisms underlying cancer evolution. Cancers 13, 1380 (2021).","journal-title":"Cancers"},{"key":"5668_CR68","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41586-021-03648-3","volume":"595","author":"S Salehi","year":"2021","unstructured":"Salehi, S. et al. Clonal fitness inferred from time-series modelling of single-cell cancer genomes. Nature 595, 585\u2013590 (2021).","journal-title":"Nature"},{"key":"5668_CR69","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1016\/j.cell.2021.11.017","volume":"184","author":"S Raghavan","year":"2021","unstructured":"Raghavan, S. et al. Microenvironment drives cell state, plasticity, and drug response in pancreatic cancer. Cell 184, 6119\u20136137.e6126 (2021).","journal-title":"Cell"},{"key":"5668_CR70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20314-w","volume":"12","author":"M Li","year":"2021","unstructured":"Li, M. et al. Core transcription regulatory circuitry orchestrates corneal epithelial homeostasis. Nat. Commun. 12, 1\u201314 (2021).","journal-title":"Nat. Commun."},{"key":"5668_CR71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-13993-7","volume":"11","author":"Y Yasumizu","year":"2020","unstructured":"Yasumizu, Y. et al. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nat. Commun. 11, 1\u201313 (2020).","journal-title":"Nat. Commun."},{"key":"5668_CR72","first-page":"1","volume":"13","author":"JI Warrick","year":"2022","unstructured":"Warrick, J. I. et al. FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation. Nat. Commun. 13, 1\u201317 (2022).","journal-title":"Nat. Commun."},{"key":"5668_CR73","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1158\/1078-0432.CCR-20-4796","volume":"27","author":"H Wang","year":"2021","unstructured":"Wang, H. et al. Single-Cell Analyses Reveal Mechanisms of Cancer Stem Cell Maintenance and Epithelial\u2013Mesenchymal Transition in Recurrent Bladder CancerscRNA-and scATAC-Seq Analyses of Human Bladder Cancer. Clin. Cancer Res. 27, 6265\u20136278 (2021).","journal-title":"Clin. Cancer Res."},{"key":"5668_CR74","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/jcmm.14767","volume":"24","author":"R Cao","year":"2020","unstructured":"Cao, R. et al. An EMT\u2010related gene signature for the prognosis of human bladder cancer. J. Cell. Mol. Med. 24, 605\u2013617 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"5668_CR75","doi-asserted-by":"publisher","first-page":"e163","DOI":"10.1038\/oncsis.2015.21","volume":"4","author":"C Franzen","year":"2015","unstructured":"Franzen, C. et al. Urothelial cells undergo epithelial-to-mesenchymal transition after exposure to muscle invasive bladder cancer exosomes. Oncogenesis 4, e163\u2013e163 (2015).","journal-title":"Oncogenesis"},{"key":"5668_CR76","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.ebiom.2019.08.012","volume":"47","author":"Z Chen","year":"2019","unstructured":"Chen, Z. et al. TGF-\u03b2-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation. EBioMedicine 47, 208\u2013220 (2019).","journal-title":"EBioMedicine"},{"key":"5668_CR77","unstructured":"Tseng, W.-C., Chuang, C.-W., Yang, M.-H., Pan, C.-C. & Tarng, D.-C. In Urologic Oncology: Seminars and Original Investigations. 485. e415\u2013485. e424 (Elsevier)."},{"key":"5668_CR78","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.3390\/cancers13205135","volume":"13","author":"AR Subbalakshmi","year":"2021","unstructured":"Subbalakshmi, A. R. et al. KLF4 Induces Mesenchymal\u2013Epithelial Transition (MET) by Suppressing Multiple EMT-Inducing Transcription Factors. Cancers 13, 5135 (2021).","journal-title":"Cancers"},{"key":"5668_CR79","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.tcb.2020.07.003","volume":"30","author":"B Bakir","year":"2020","unstructured":"Bakir, B., Chiarella, A. M., Pitarresi, J. R. & Rustgi, A. K. EMT, MET, plasticity, and tumor metastasis. Trends cell Biol. 30, 764\u2013776 (2020).","journal-title":"Trends cell Biol."},{"key":"5668_CR80","doi-asserted-by":"publisher","first-page":"e108647","DOI":"10.15252\/embj.2021108647","volume":"40","author":"S Brabletz","year":"2021","unstructured":"Brabletz, S., Schuhwerk, H., Brabletz, T. & Stemmler, M. P. Dynamic EMT: a multi\u2010tool for tumor progression. EMBO J. 40, e108647 (2021).","journal-title":"EMBO J."},{"key":"5668_CR81","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.devcel.2021.02.028","volume":"56","author":"Y Katsuno","year":"2021","unstructured":"Katsuno, Y. & Derynck, R. Epithelial plasticity, epithelial-mesenchymal transition, and the TGF-\u03b2 family. Dev. Cell 56, 726\u2013746 (2021).","journal-title":"Dev. Cell"},{"key":"5668_CR82","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.3390\/biom10081159","volume":"10","author":"M Ashrafizadeh","year":"2020","unstructured":"Ashrafizadeh, M. et al. Role of microRNA\/epithelial-to-mesenchymal transition axis in the metastasis of bladder cancer. Biomolecules 10, 1159 (2020).","journal-title":"Biomolecules"},{"key":"5668_CR83","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.cell.2011.07.026","volume":"146","author":"PB Gupta","year":"2011","unstructured":"Gupta, P. B. et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 146, 633\u2013644 (2011).","journal-title":"Cell"},{"key":"5668_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-020-3413-1","volume":"21","author":"Y Xin","year":"2020","unstructured":"Xin, Y., Cummins, B. & Gedeon, T. Multistability in the epithelial-mesenchymal transition network. BMC Bioinforma. 21, 1\u201317 (2020).","journal-title":"BMC Bioinforma."},{"key":"5668_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-21884-z","volume":"12","author":"AF Aissa","year":"2021","unstructured":"Aissa, A. F. et al. Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer. Nat. Commun. 12, 1\u201325 (2021).","journal-title":"Nat. Commun."},{"key":"5668_CR86","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","volume":"175","author":"M Sade-Feldman","year":"2018","unstructured":"Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 175, 998\u20131013.e1020 (2018).","journal-title":"Cell"},{"key":"5668_CR87","doi-asserted-by":"crossref","unstructured":"Ors, A. et al. Estrogen regulates divergent transcriptional and epigenetic cell states in breast cancer. Nucleic Acids Research 50, 11492\u201311508 (2022).","DOI":"10.1093\/nar\/gkac908"},{"key":"5668_CR88","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko, I. et al. Identification of the tumour transition states occurring during EMT. Nature 556, 463\u2013468 (2018).","journal-title":"Nature"},{"key":"5668_CR89","doi-asserted-by":"publisher","first-page":"e109221","DOI":"10.15252\/embj.2021109221","volume":"41","author":"R Vegliante","year":"2022","unstructured":"Vegliante, R., Pastushenko, I. & Blanpain, C. Deciphering functional tumor states at single\u2010cell resolution. EMBO J. 41, e109221 (2022).","journal-title":"EMBO J."},{"key":"5668_CR90","doi-asserted-by":"publisher","first-page":"110162","DOI":"10.1016\/j.jtbi.2020.110162","volume":"490","author":"EB Gunnarsson","year":"2020","unstructured":"Gunnarsson, E. B., De, S., Leder, K. & Foo, J. Understanding the role of phenotypic switching in cancer drug resistance. J. Theor. Biol. 490, 110162 (2020).","journal-title":"J. Theor. Biol."},{"key":"5668_CR91","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1093\/annonc\/mdw677","volume":"28","author":"S De","year":"2017","unstructured":"De, S. & Ganesan, S. Looking beyond drivers and passengers in cancer genome sequencing data. Ann. Oncol. 28, 938\u2013945 (2017).","journal-title":"Ann. Oncol."},{"key":"5668_CR92","doi-asserted-by":"crossref","unstructured":"Murphy, N. et al. Single-Cell Sequencing in Genitourinary Malignancies. Single-cell Sequencing and Methylation 1255, 153\u2013164 (2020).","DOI":"10.1007\/978-981-15-4494-1_13"},{"key":"5668_CR93","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3390\/cells9010235","volume":"9","author":"A Abugomaa","year":"2020","unstructured":"Abugomaa, A., Elbadawy, M., Yamawaki, H., Usui, T. & Sasaki, K. Emerging roles of cancer stem cells in bladder cancer progression, tumorigenesis, and resistance to chemotherapy: a potential therapeutic target for bladder cancer. Cells 9, 235 (2020).","journal-title":"Cells"},{"key":"5668_CR94","doi-asserted-by":"publisher","first-page":"5297","DOI":"10.3390\/cancers13215297","volume":"13","author":"E Lavallee","year":"2021","unstructured":"Lavallee, E., Sfakianos, J. P. & Mulholland, D. J. Tumor Heterogeneity and Consequences for Bladder Cancer Treatment. Cancers 13, 5297 (2021).","journal-title":"Cancers"},{"key":"5668_CR95","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pbiomolbio.2012.05.001","volume":"110","author":"S Huang","year":"2012","unstructured":"Huang, S. Tumor progression: chance and necessity in Darwinian and Lamarckian somatic (mutationless) evolution. Prog. Biophys. Mol. Biol. 110, 69\u201386 (2012).","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"5668_CR96","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/bies.201100031","volume":"34","author":"S Huang","year":"2012","unstructured":"Huang, S. The molecular and mathematical basis of Waddington\u2019s epigenetic landscape: A framework for post\u2010Darwinian biology? Bioessays 34, 149\u2013157 (2012).","journal-title":"Bioessays"},{"key":"5668_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms3467","volume":"4","author":"AO Pisco","year":"2013","unstructured":"Pisco, A. O. et al. Non-Darwinian dynamics in therapy-induced cancer drug resistance. Nat. Commun. 4, 1\u201311 (2013).","journal-title":"Nat. Commun."},{"key":"5668_CR98","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.cell.2021.02.020","volume":"184","author":"WC Hahn","year":"2021","unstructured":"Hahn, W. C. et al. An expanded universe of cancer targets. Cell 184, 1142\u20131155 (2021).","journal-title":"Cell"},{"key":"5668_CR99","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/s43018-021-00250-4","volume":"2","author":"F Chen","year":"2021","unstructured":"Chen, F. et al. Moving pan-cancer studies from basic research toward the clinic. Nat. Cancer 2, 879\u2013890 (2021).","journal-title":"Nat. Cancer"},{"key":"5668_CR100","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature22794","volume":"546","author":"SM Shaffer","year":"2017","unstructured":"Shaffer, S. M. et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature 546, 431\u2013435 (2017).","journal-title":"Nature"},{"key":"5668_CR101","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-16212-w","volume":"11","author":"R Vander Velde","year":"2020","unstructured":"Vander Velde, R. et al. Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures. Nat. Commun. 11, 1\u201313 (2020).","journal-title":"Nat. Commun."},{"key":"5668_CR102","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.3390\/cells9122601","volume":"9","author":"M Swayden","year":"2020","unstructured":"Swayden, M., Chhouri, H., Anouar, Y. & Grumolato, L. Tolerant\/persister cancer cells and the path to resistance to targeted therapy. Cells 9, 2601 (2020).","journal-title":"Cells"},{"key":"5668_CR103","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","volume":"15","author":"I Dagogo-Jack","year":"2018","unstructured":"Dagogo-Jack, I. & Shaw, A. T. Tumour heterogeneity and resistance to cancer therapies. Nat. Rev. Clin. Oncol. 15, 81\u201394 (2018).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"5668_CR104","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1158\/1078-0432.CCR-14-1429","volume":"21","author":"M Jamal-Hanjani","year":"2015","unstructured":"Jamal-Hanjani, M., Quezada, S. A., Larkin, J. & Swanton, C. Translational implications of tumor heterogeneity. Clin. cancer Res. 21, 1258\u20131266 (2015).","journal-title":"Clin. cancer Res."},{"key":"5668_CR105","doi-asserted-by":"publisher","first-page":"zcab027","DOI":"10.1093\/narcan\/zcab027","volume":"3","author":"S Sahoo","year":"2021","unstructured":"Sahoo, S. et al. A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells. NAR cancer 3, zcab027 (2021).","journal-title":"NAR cancer"},{"key":"5668_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12859-021-04344-9","volume":"22","author":"DR Stirling","year":"2021","unstructured":"Stirling, D. R. et al. CellProfiler 4: improvements in speed, utility and usability. BMC Bioinforma. 22, 1\u201311 (2021).","journal-title":"BMC Bioinforma."},{"key":"5668_CR107","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e3529 (2021).","journal-title":"Cell"},{"key":"5668_CR108","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/s41586-018-0414-6","volume":"560","author":"G La Manno","year":"2018","unstructured":"La Manno, G. et al. RNA velocity of single cells. Nature 560, 494\u2013498 (2018).","journal-title":"Nature"},{"key":"5668_CR109","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cell.2018.05.061","volume":"174","author":"D Van Dijk","year":"2018","unstructured":"Van Dijk, D. et al. Recovering gene interactions from single-cell data using data diffusion. Cell 174, 716\u2013729.e727 (2018).","journal-title":"Cell"},{"key":"5668_CR110","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1093\/nar\/gkab043","volume":"49","author":"M Elosua-Bayes","year":"2021","unstructured":"Elosua-Bayes, M., Nieto, P., Mereu, E., Gut, I. & Heyn, H. SPOTlight: seeded NMF regression to deconvolute spatial transcriptomics spots with single-cell transcriptomes. Nucleic acids Res. 49, e50\u2013e50 (2021).","journal-title":"Nucleic acids Res."},{"key":"5668_CR111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-022-02835-3","volume":"23","author":"K Su","year":"2022","unstructured":"Su, K. et al. NetAct: a computational platform to construct core transcription factor regulatory networks using gene activity. Genome Biol. 23, 1\u201321 (2022).","journal-title":"Genome Biol."},{"key":"5668_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12918-018-0594-6","volume":"12","author":"B Huang","year":"2018","unstructured":"Huang, B. et al. RACIPE: a computational tool for modeling gene regulatory circuits using randomization. BMC Syst. Biol. 12, 1\u201312 (2018).","journal-title":"BMC Syst. Biol."},{"key":"5668_CR113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-4598-9-3","volume":"9","author":"W-J Kim","year":"2010","unstructured":"Kim, W.-J. et al. Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer. Mol. cancer 9, 1\u20139 (2010).","journal-title":"Mol. cancer"},{"key":"5668_CR114","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/ng1923","volume":"38","author":"N Stransky","year":"2006","unstructured":"Stransky, N. et al. Regional copy number\u2013independent deregulation of transcription in cancer. Nat. Genet. 38, 1386\u20131396 (2006).","journal-title":"Nat. Genet."},{"key":"5668_CR115","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/ng1061","volume":"33","author":"L Dyrskj\u00f8t","year":"2003","unstructured":"Dyrskj\u00f8t, L. et al. Identifying distinct classes of bladder carcinoma using microarrays. Nat. Genet. 33, 90\u201396 (2003).","journal-title":"Nat. Genet."},{"key":"5668_CR116","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1200\/JCO.2005.03.2375","volume":"24","author":"M Sanchez-Carbayo","year":"2006","unstructured":"Sanchez-Carbayo, M., Socci, N. D., Lozano, J., Saint, F. & Cordon-Cardo, C. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J. Clin. Oncol. 24, 778\u2013789 (2006).","journal-title":"J. Clin. Oncol."},{"key":"5668_CR117","doi-asserted-by":"publisher","first-page":"e74250","DOI":"10.1371\/journal.pone.0074250","volume":"8","author":"R Aguirre-Gamboa","year":"2013","unstructured":"Aguirre-Gamboa, R. et al. SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis. PloS one 8, e74250 (2013).","journal-title":"PloS one"},{"key":"5668_CR118","doi-asserted-by":"publisher","unstructured":"Biswas, A. BLCA-resources. Zenodo https:\/\/doi.org\/10.5281\/zenodo.10001845 (2023).","DOI":"10.5281\/zenodo.10001845"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-05668-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-05668-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-05668-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T10:09:48Z","timestamp":1703153388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-05668-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,21]]},"references-count":118,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5668"],"URL":"https:\/\/doi.org\/10.1038\/s42003-023-05668-3","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,21]]},"assertion":[{"value":"24 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1292"}}